Prevention & Chronic Conditions

About

Cardiovascular disease (CVD) is a significant and ever-growing problem in the UK, accounting for nearly one-third of all deaths and leading to significant morbidity. Globally CVD accounts for 31% of mortality, mainly from heart disease and cerebrovascular accident.

The burden of CVD can be ameliorated by careful risk modification and primary prevention is an important priority for all developers of health policy. Strong consensus exists between international guidelines regarding the necessity of smoking cessation, weight optimisation and exercise, although guidelines have slightly different approaches to hypertension and vary considerably regarding their approach to optimal lipid profile, which remains a contentious issue.

Articles

Corrigendum to: Pulmonary Hypertension in Heart Failure Patients

Published:

23 October 2020

Citation:

Cardiac Failure Review 2020;6:e30.

PVI Versus Amiodarone in AF and CHF

Published:

09 April 2020

Citation:

Cardiac Failure Review 2020;6:e04.

Pulmonary Hypertension in Heart Failure Patients

Published:

09 April 2020

Citation:

Cardiac Failure Review 2020;6:e05.

Update from the National Cardiogenic Shock Initiative

Published:

19 November 2019

Citation:

Interventional Cardiology Review 2019;14(3 Suppl 2):19-20.